Eligibility Major Depressive Disorder NCT02330068

1 Formulários

StudyEvent: Eligibility
1. Eligibility Major Depressive Disorder NCT02330068

Name

Tipo

Description | Question | Decode (Coded Value)

Tipo de dados

Alias

Inclusion Criteria

Item Group

C1512693 (UMLS CUI)

Outpatients | Inpatients | DEPRESSIVE DISORDER MAJOR WITHOUT PSYCHOTIC FEATURE

Item

outpatients or inpatients with nonpsychotic major depressive disorder (mdd).

boolean

C0029921 (UMLS CUI [1])
C0021562 (UMLS CUI [2])
C0743081 (UMLS CUI [3])

QIDS

Item

a score of >16 on the qids

boolean

C4300148 (UMLS CUI [1])

Antidepressant therapy Appropriate Outpatients | Antidepressant therapy Appropriate Inpatients

Item

outpatients or inpatients for whom antidepressant treatment is deemed appropriate by the treating clinician

boolean

C1096649 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0029921 (UMLS CUI [1,3])
C1096649 (UMLS CUI [2,1])
C1548787 (UMLS CUI [2,2])
C0021562 (UMLS CUI [2,3])

Age

Item

subjects who are between 18-55 years of age

boolean

C0001779 (UMLS CUI [1])

Exclusion Criteria

Item Group

C0680251 (UMLS CUI)

Medical contraindication Citalopram

Item

contraindications to citalopram treatment

boolean

C1301624 (UMLS CUI [1,1])
C0008845 (UMLS CUI [1,2])

Axis I diagnosis | Axis II diagnosis | Exception Depressive disorder

Item

axis i or ii disorder other than depression that is the primary reason for seeking treatment intervention and/or psychiatric care

boolean

C0270287 (UMLS CUI [1])
C0270288 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0011581 (UMLS CUI [3,2])

Healthy Control | First Degree Relative Axis I diagnosis

Item

for healthy controls, a first degree relative who has been diagnosed with an axis i disorder

boolean

C2986479 (UMLS CUI [1])
C1517194 (UMLS CUI [2,1])
C0270287 (UMLS CUI [2,2])

Schizophrenia | Schizoaffective Disorder | Bipolar I disorder

Item

patients with schizophrenia, schizoaffective disorder, or bipolar i disorder

boolean

C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
C0853193 (UMLS CUI [3])

Antidepressant therapy | Fluoxetine | Antidepressive Agents To be stopped | Status pre- Initiation Citalopram

Item

antidepressant treatment within 4 days of study (1 week if fluoxetine). subjects currently on antidepressant medication with subtherapeutic results in terms of depression management after providing informed consent, will undergo a medication taper and discontinuation prior to initiation of citalopram treatment. the subject must be off of previous antidepressants for at least 4 days week prior to starting citalopram (1 week if fluoxetine). the subject will be closely monitored by the research study psychiatrist (with or without additional monitoring from primary clinical psychiatric providers). the medication taper is left up to the research study psychiatrist in consultation with patient's primary care or psychiatric provider. study subjects who cannot be safely tapered from their medication or experience adverse effects during the taper will be excluded from the study

boolean

C1096649 (UMLS CUI [1])
C0016365 (UMLS CUI [2])
C0003289 (UMLS CUI [3,1])
C1272691 (UMLS CUI [3,2])
C0332152 (UMLS CUI [4,1])
C1704686 (UMLS CUI [4,2])
C0008845 (UMLS CUI [4,3])

Antidepressive Agents Management Nicotine Dependence | Antidepressive Agents Management Chronic pain | Antidepressive Agents Migraine prophylaxis

Item

study subjects using their antidepressant medication for management of nicotine dependence, chronic pain, migraine prophylaxis, or other diagnoses will not be eligible for the study

boolean

C0003289 (UMLS CUI [1,1])
C0376636 (UMLS CUI [1,2])
C0028043 (UMLS CUI [1,3])
C0003289 (UMLS CUI [2,1])
C0376636 (UMLS CUI [2,2])
C0150055 (UMLS CUI [2,3])
C0003289 (UMLS CUI [3,1])
C1142085 (UMLS CUI [3,2])

Item

subjects currently on antipsychotic medications (i.e., typical or atypical antipsychotic drugs) and mood stabilizing(e.g., lithium, carbamazepine, valproate, lamotrigine, gabapentin, or other anticonvulsants) are not eligible for the study. trazodone, melatonin, and diphenhydramine may be used as rescue medications for insomnia. benzodiazepines may be used for treatment of anxiety, not to exceed 4 mg/24 hour of lorazepam

boolean

C0040615 (UMLS CUI [1])
C2917392 (UMLS CUI [2])
C1276996 (UMLS CUI [3])
C1276998 (UMLS CUI [4])
C0023870 (UMLS CUI [5])
C0006949 (UMLS CUI [6])
C0080356 (UMLS CUI [7])
C0064636 (UMLS CUI [8])
C0060926 (UMLS CUI [9])
C0003286 (UMLS CUI [10])
C0683607 (UMLS CUI [11,1])
C0040805 (UMLS CUI [11,2])
C0917801 (UMLS CUI [11,3])
C0683607 (UMLS CUI [12,1])
C0025219 (UMLS CUI [12,2])
C0917801 (UMLS CUI [12,3])
C0683607 (UMLS CUI [13,1])
C0012522 (UMLS CUI [13,2])
C0917801 (UMLS CUI [13,3])
C0683607 (UMLS CUI [14,1])
C0005064 (UMLS CUI [14,2])
C0003467 (UMLS CUI [14,3])
C0683607 (UMLS CUI [15,1])
C0024002 (UMLS CUI [15,2])
C0003467 (UMLS CUI [15,3])

Antibiotics | ANTIBIOTICS FOR TOPICAL USE allowed

Item

subjects who are currently on an antibiotic or an antibiotic within 2 weeks. (topical antibiotics are ok)

boolean

C0003232 (UMLS CUI [1])
C3653723 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])

Aspirin Daily | NSAIDs Daily | Warfarin Daily | Aspirin Low Dose allowed

Item

daily use of aspirin, nsaid's or warfarin (low dose of baby aspirin ok)

boolean

C0004057 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C0003211 (UMLS CUI [2,1])
C0332173 (UMLS CUI [2,2])
C0043031 (UMLS CUI [3,1])
C0332173 (UMLS CUI [3,2])
C2608320 (UMLS CUI [4,1])
C0683607 (UMLS CUI [4,2])

Informed Consent Unable

Item

subjects unable to give informed consent are excluded

boolean

C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])

Pregnancy

Item

pregnant subjects will be excluded

boolean

C0032961 (UMLS CUI [1])

Breast Feeding | Breast Feeding Continue Planned

Item

subjects who are currently breastfeeding and who plan to continue breastfeeding will be excluded

boolean

C0006147 (UMLS CUI [1])
C0006147 (UMLS CUI [2,1])
C0549178 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])

Postmenopausal state

Item

postmenopausal women are not eligible for this study

boolean

C0232970 (UMLS CUI [1])

Voltar ao início da página

ID

Descrição

Link

Palavras-chave

Versões (1)

Titular dos direitos

Transferido a

DOI

Licença

Comentários do modelo :

Comentários do grupo de itens para :

Comentários do item para :

Eligibility Major Depressive Disorder NCT02330068